377 related articles for article (PubMed ID: 18442787)
21. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
23. Reactivation of inflammatory bowel disease in a mouse model of depression.
Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
[TBL] [Abstract][Full Text] [Related]
24. Dextran sulfate sodium-induced colitis generates a transient thymic involution--impact on thymocyte subsets.
Fritsch Fredin M; Elgbratt K; Svensson D; Jansson L; Melgar S; Hultgren Hörnquist E
Scand J Immunol; 2007 May; 65(5):421-9. PubMed ID: 17444952
[TBL] [Abstract][Full Text] [Related]
25. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
[TBL] [Abstract][Full Text] [Related]
26. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis.
Yablecovitch D; Shabat-Simon M; Aharoni R; Eilam R; Brenner O; Arnon R
J Pharmacol Exp Ther; 2011 May; 337(2):391-9. PubMed ID: 21310817
[TBL] [Abstract][Full Text] [Related]
28. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis.
Lee M; Kovacs-Nolan J; Yang C; Archbold T; Fan MZ; Mine Y
J Agric Food Chem; 2009 Mar; 57(6):2233-40. PubMed ID: 19231858
[TBL] [Abstract][Full Text] [Related]
29. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
30. Influence of Slc11a1 (formerly Nramp1) on DSS-induced colitis in mice.
Jiang HR; Gilchrist DS; Popoff JF; Jamieson SE; Truscott M; White JK; Blackwell JM
J Leukoc Biol; 2009 Apr; 85(4):703-10. PubMed ID: 19116231
[TBL] [Abstract][Full Text] [Related]
31. PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis.
Rijcken E; Mennigen RB; Schaefer SD; Laukoetter MG; Anthoni C; Spiegel HU; Bruewer M; Senninger N; Krieglstein CF
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G446-52. PubMed ID: 17510197
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
33. Mice with experimental colitis show an altered metabolism with decreased metabolic rate.
Melgar S; Bjursell M; Gerdin AK; Svensson L; Michaëlsson E; Bohlooly-Y M
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G165-72. PubMed ID: 16844678
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
Ikenoue Y; Tagami T; Murata M
Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
[TBL] [Abstract][Full Text] [Related]
35. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
36. Chemically induced mouse models of intestinal inflammation.
Wirtz S; Neufert C; Weigmann B; Neurath MF
Nat Protoc; 2007; 2(3):541-6. PubMed ID: 17406617
[TBL] [Abstract][Full Text] [Related]
37. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.
Katada K; Yoshida N; Suzuki T; Okuda T; Mizushima K; Takagi T; Ichikawa H; Naito Y; Cepinskas G; Yoshikawa T
Inflamm Res; 2008 Feb; 57(2):84-91. PubMed ID: 18288458
[TBL] [Abstract][Full Text] [Related]
38. Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis.
Hong T; Yang Z; Lv CF; Zhang Y
Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):391-7. PubMed ID: 22564173
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis.
Anthoni C; Laukoetter MG; Rijcken E; Vowinkel T; Mennigen R; Müller S; Senninger N; Russell J; Jauch J; Bergmann J; Granger DN; Krieglstein CF
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1131-7. PubMed ID: 16423918
[TBL] [Abstract][Full Text] [Related]
40. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
